Showing results (291-300 of 328) with videos related to
Sort By:
Pageof 33
Annals of Hematology|March 4, 2003
Reduced non-relapse mortality after reduced intensity conditioning in advanced chronic lymphocytic leukemiaJ Schetelig, C Thiede, M Bornhäuser, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 6, 2000
Clinical phase I dose escalation and pharmacokinetic study of high-dose chemotherapy with treosulfan and autologous peripheral blood stem cell transplantation in patients with advanced malignanciesM E Scheulen, R A Hilger, C Oberhoff, et al.Journal of Cancer Research and Clinical Oncology|July 13, 2022
The OUTREACH study: oncologists of German university hospitals in rotation on a palliative care unit-evaluation of attitude and competence in palliative care and hospiceT Biersching, A Schweda, K Oechsle, et al.Medizinische Klinik (Munich, Germany : 1983)|April 12, 1996
[Intensive post-remission therapy in acute myeloid leukemia. Results of a prospective comparative study by the South Germany Hemoblastosis Group]G Hübner, H Link, P Schönrock-Nabulsi, et al.Journal of Internal Medicine|October 14, 2017
What is the outcome in patients with acute leukaemia who survive severe acute graft-versus-host disease?O Ringdén, M Labopin, B Sadeghi, et al.Leukemia|November 28, 2002
Nonmyeloablative stem cell transplantation in adults with high-risk ALL may be effective in early but not in advanced diseaseR Arnold, G Massenkeil, M Bornhäuser, et al.Clinical and Experimental Immunology|January 23, 2016
Abundant cytomegalovirus (CMV) reactive clonotypes in the CD8(+) T cell receptor alpha repertoire following allogeneic transplantationC S Link, A Eugster, F Heidenreich, et al.Leukemia|January 21, 2006
Inhibition of retinoic acid receptor signaling by Ski in acute myeloid leukemiaM Ritter, D Kattmann, S Teichler, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 4, 2011
Induction therapy of AML with ara-C plus daunorubicin versus ara-C plus gemtuzumab ozogamicin: a randomized phase II trial in elderly patientsU Brunnberg, M Mohr, R Noppeney, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 11, 2016
Reduced intensity allogeneic stem cell transplantation for follicular lymphoma relapsing after an autologous transplant achieves durable long-term disease control: an analysis from the Lymphoma Working Party of the EBMT†S P Robinson, A Boumendil, H Finel, et al.Pageof 33